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Abstract
Objective—To follow-up on earlier studies of the leukaemogenicity of occupational ionising 
radiation exposure.
Methods—We conducted a nested case-control analysis of leukaemia mortality in a pooled 
cohort of US nuclear workers followed through 2005. Each case was matched to four controls on 
attained age. Exposures were estimated from available records. General relative risk models were 
used to estimate the excess relative risk (ERR) of leukaemia, excluding chronic lymphocytic 
(CLL), acute myeloid leukaemia, chronic myeloid leukaemia and CLL while controlling for 
potential confounders. Preferred exposure lags and time-windows of risks were calculated using 
joint maximum likelihood. Dose-response was also examined using linear, linear-quadratic, 
categorical and restricted cubic spline models.
Results—There were 369 leukaemia deaths in 105 245 US nuclear workers. The adjusted ERR 
for non-CLL leukaemia was 0.09 (95% CI −0.17 to 0.65) per 100 mGy. Elevated non-CLL risks 
were observed from exposures occurring 6–14 years prior to attained age of cases (ERR per 100 
mGy=1.9; 95% CI <0 to 8.0). Lagged models indicated non-linearity of risk at very low (<10 
mGy) and high (>100 mGy) doses, which contributed to the imprecision of results in linear 
models. Similar risk attenuation was not evident in time-windows-based models.
Conclusions—Risk estimates were in reasonable agreement with previous estimates, with the 
temporality of non-CLL leukaemia risk as a dominant factor in dose-response analyses. Future 
research should focus on methods that improve evaluations of the dose-response, particularly in 
the low-dose range.
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INTRODUCTION
Most information on the leukaemogenicity of ionising radiation stems from studies of 
radiation therapy patients and survivors of the atomic bomb blasts in 1945.12 In particular, 
the Life-Span Study (LSS) of the Japanese atomic bomb survivors forms the foundation for 
current worker protection standards. The LSS has the advantages of large size (~87 000), all 
ages at exposure, both sexes, long follow-up period and doses over a range of interest (0–4 
Gy with 60% less than 0.1 Gy), although questions remain concerning the translation of 
risks to workers who are intermittently exposed to low doses delivered at low dose rates. A 
preferred alternative is the direct estimation of risk in working populations; however, most 
occupational studies lack sufficient statistical power for examining rare outcomes such as 
leukaemia. As such, recent studies have estimated leukaemia risk in nuclear workers using 
pooled, or meta-analyses, that offer improved precision.3–7 In particular, Daniels and 
Schubauer–Berigan conducted5 a meta-analysis using information from occupational and 
environmental studies to estimate the excess relative risk (ERR) of leukaemia, excluding the 
chronic lymphocytic subtype (CLL). The summary estimate from 10 studies (ERR at 100 
mGy=0.19; (95% CI 0.07 to 0.32) was in reasonable agreement with the LSS. Nevertheless, 
a meta-analytic approach relies on the quality of data available in the published literature; 
therefore, these analyses may be vulnerable to biases in the source information. Moreover, 
studies have typically relied on models that assume risk is linear or linear-quadratic in dose 
for a heterogeneous group of diseases comprising non-CLL leukaemia. Few studies have 
examined departures from linearity in the dose-response or risk differences by leukaemia 
subtype.
This study extends follow-up of workers previously studied by Schubauer–Berigan et al34 
and expands the cohort to include workers from the Idaho National Laboratory.8 Previous 
analyses reported estimates of the ERR of mortality per unit dose for non-CLL leukaemia 
that reasonably agreed with the LSS4; however, there was evidence of risk attenuation at 
doses above 100 mGy and temporal patterns in risk that varied with time since exposure.4 
The purpose of the current study is to: (1) improve upon previous estimates through 
additional follow-up and cohort expansion; (2) report on the risk by leukaemia subtype and 
(3) further evaluate the shape and temporal behaviour of the dose-response.
METHODS
Study cohort
This research complied with the requirements of the Federal Policy for Protection of Human 
Subjects (10CFR745 or, where applicable, 45CFR46), and was reviewed by the National 
Institute for Occupational Safety and Health (NIOSH) Human Subjects Review Board to 
ensure that the rights and welfare of study subjects were protected.
The study population consisted of workers who were employed at the Hanford Site 
(Hanford) near Richland, Washington; the Savannah River Site (SRS) near Aiken, South 
Carolina; the Oak Ridge National Laboratory (ORNL) in Oak Ridge, Tennessee; the Los 
Alamos National Laboratory (LANL), including the Zia Company employees, in Los 
Alamos, New Mexico; the Idaho National Laboratory (INL) near Idaho Falls, Idaho; and the 
Daniels et al. Page 2
Occup Environ Med. Author manuscript; available in PMC 2015 September 09.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Portsmouth Naval Shipyard (PNS) in Kittery, Maine. Eligible workers were monitored for 
radiation exposure and employed at one or more of the primary facilities for at least 30 days. 
Hanford, LANL and ORNL workers were further restricted to those first employed on or 
after 1 January 1951 to reduce exposure errors believed associated with early dosimetry 
practices at Manhattan Engineering District Facilities.4 Vital status ascertainment was 
extended through 31 December 2005, adding 9–15 years of follow-up to the previous study.
Cases were decedents with leukaemia (ICD-9: 204–208; ICD-10: C91–C95, excluding 
leukaemic reticuloendotheliosis (C91.4)), identified as the underlying cause of death. 
Distinctions were made by major subtypes, namely: CLL, acute lymphoid leukaemia (ALL), 
chronic myeloid leukaemia (CML) and acute myeloid leukaemia (AML). Non-CLL cases 
comprised all-acute, and subacute leukaemias, and myeloid or monocytic leukaemias, 
excluding CLL-indeterminate cases that were defined as cases lacking sufficient information 
on cell type and severity to determine non-CLL status (ie, ICD-9 codes: 204.9, 208.1, 208.9; 
ICD-10 codes: C91.9, C95.9, C95.1). Similarly, AML-indeterminate cases were defined as 
acute leukaemias of unspecified cell type (ie, ICD-9 code: 208.0; ICD-10 code: C95.0). Four 
controls were selected for each case using incidence density sampling.9 Controls were 
matched to their respective case on attained age and by primary study group, whereby, 
Group I risk sets were formed from the previously studied group of Hanford, LANL/Zia, 
ORNL, PNS and SRS workers,34 and Group II risk sets contained the INL workers.8 This 
group matching was done to maximise utility of information collected on cases and controls 
selected for the previous study.
Exposure
The primary exposure was low linear energy transfer (low-LET) ionising radiation from all 
occupational sources, including work-related medical x-ray examinations (WRX) conducted 
during routine physical examinations by the employer.1011 Workplace exposures to neutrons 
and internally deposited plutonium were also considered as potential cofactors in dose-
response analyses. External ionising radiation exposure measurements for each study 
participant were abstracted from site dosimetry databases and dose registries maintained by 
the US Department of Energy (DOE) and US Nuclear Regulatory Commission (NRC). All 
doses were quantified in terms of absorbed dose to haematopoietic tissue using methods 
described elsewhere.411–13 There were five exposure variables describing ionising radiation 
dose (ie, gamma, tritium, WRX, neutron and plutonium). Low-LET exposure was calculated 
by summing doses from whole-body gamma, tritium and WRX sources.
Benzene exposures were assessed using a job exposure matrix to assign task-specific 
benzene ‘scores’ that were based on combinations of qualitative ratings of exposure 
intensity and frequency over time. Potentially exposed workers were identified using 
available employment information on job assignment (eg, job title, division and department) 
and work location in each study facility (eg, area, building and room). Tasks were identified 
and characterised using site-monitoring records and process information. Task-based scores 
were calculated for each study subject and period of employment, which were then 
accumulated over the observation period.
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Socioeconomic status
The methods used to assign socioeconomic status (SES) are described elsewhere.48 In 
general, the job title at first hire for each worker was related to an occupational code listed in 
the 1980 US Bureau of Census. The first job title was chosen because it is thought that 
initial employment provides a better marker for some lifestyle factors (eg, smoking) that are 
typically established in adolescence and early adulthood.4814 Each of these codes was then 
assigned to one of six SES categories, namely (from high to low SES): professional, 
intermediate, skilled non-manual, skilled manual, partly skilled and unskilled.
STATISTICAL METHODS
All statistical analyses were conducted using SAS software.15 Primary modelling used 
general relative risk models that represent a linear trend in radiation dose.16 Relative risk 
models followed the general form
where α is the radiation risk coefficient; βi is the coefficient for the ith covariate of 1, 2 …n 
covariates indexed by multiplicative factors, Xi; and γj is the radiation weighting factor for 
the jth dose variable of three linear dose covariates, D. For all models, three radiation 
sources were considered: (1) low-LET (D1) irradiation; (2) plutonium deposition (D2); and 
(3) neutron radiation (D3). Setting the low-LET radiation weighting factor to unity (γ1=1) 
allowed solutions to radiation weights for plutonium and neutron doses that can be 
compared with standard values. Profile likelihood-based (PL-based) two-sided 95% CIs 
were calculated for model parameter estimates.
Effect modification was evaluated by likelihood ratio test (LRT) at the 0.05 critical level of 
the cross-product term of the potential effect modifier and radiation dose. Factors evaluated 
were: sex, race (White non-Hispanic/all others), birth cohort (tertiles), period of first hire 
(tertiles), facility of longest employment duration and study group (Group I vs Group II). 
Potential confounders were incorporated into models when causing >15% relative change in 
the overall dose parameter estimate. To minimise the potential bias from selection of 
cutpoints for categories of birth cohort and hire date, continuous variables were constructed 
from terms calculated by restricted cubic spline (RCS) models, with three knots at the 10th, 
50th and 90th percentile of birth date and hire date, respectively.17 Because birth date and 
hire date were correlated (Pearson coefficient=0.59, p<0.001), models were restricted to 
include no more than one of these variables at a time. Final selection between birth date and 
hire date was based on a comparison of observed effect and the statistical significance of the 
covariates.
Baseline models were constructed for non-CLL leukaemia and three of the four major 
subtypes: AML, CML and CLL. There were too few cases to adequately examine ALL risks 
separately. The methods proposed by Richardson et al18 were used to simultaneously 
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estimate the preferred exposure lag by joint maximum likelihood. A preferred time-window 
of exposure was similarly estimated.
The linearity of the dose-response was examined by: (1) evaluating the fit of a quadratic 
term added to the model; (2) examining the risk by dose categories; (3) fitting RCS models 
and (4) fitting piecewise linear spline (PLS) models. Lagged categorical models used 
categories of 0–<1.0, 1–<10, 10–<50, 50–<100, and ≥100 mGy, with the lowest category as 
referent. Time-windows-based models used dose categories with cut-points defined by 
quintiles of the dose distribution of the cases for each outcome. Lagged RCS models set four 
knots at the 5th, 35th, 65th and 95th percentiles of the distribution of low-LET dose, while 
windows-based RCS models used three knots defined by the 10th, 50th and 90th percentiles 
of dose.17 PLS models were restricted to non-CLL (lagged and windows-based); both two- 
and three-piece solutions were evaluated. Model fits were judged by Akaike Information 
Criterion (AIC).19 To test improvement in fit over a linear model, LRTs were conducted 
comparing the adjusted linear-quadratic, RCS and PLS models with the adjusted linear 
model.
The effects of high-LET radiations were examined in sensitivity analyses using model 
solutions to radiation weights and by varying weighting schemes for biological 
effectiveness. Three sets of weights for low-LET, neutron and plutonium were considered: 
1, 10 and 20, which is consistent with the protection quantity ‘equivalent dose’20; 1, 11 and 
3.6, which are median radiation effectiveness factors suggested by Kocher et al21; and 1, 10 
and 1, based on the upper bound suggested by the United States Environmental Protection 
Agency (US EPA) in 1999 for α emitters deposited on bone surfaces or in bone.22 The 
current EPA-recommended value of 2 (95% CI 1 to 3) for incorporated α-emitters is within 
the range analysed.23
RESULTS
Descriptive and univariate
There were 94 517 workers from Hanford, LANL, ORNL, PNS and SRS (ie, Group I) and 
63 560 INL workers (ie, Group II). Applying the inclusion criteria, and then combining the 
two cohorts, resulted in a base cohort of 105 245. There were 30 266 deaths (28%), which 
included 8721 cancer deaths and 369 leukaemia cases. Among leukaemias, 291 cases were 
identifiable to one of four subtypes. Non-CLL leukaemia (n=264) comprised AML (n=150), 
CML (n=52), ALL (n=18), unspecified acute leukaemias (n=36) and myeloid leukaemias 
(n=2), and other non-CLL subtypes (n=6). There were 74 CLL deaths. (See Web Appendix, 
tables 1–3 for additional information on the study cohort and case distribution.)
Dose distributions were right-skewed; the average, median and maximum values of low-
LET dose lagged 2 years were 26.5 and 7.2 mGy, and 634 mGy, respectively. There were 
293 (15.9%) cases and controls exposed to tritium, 237 (12.8%) with neutron dose, 130 
(7.0%) with plutonium dose and 360 (19.5%) who were assigned benzene scores (see Web 
Appendix, table 4 for additional information on exposures).
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Univariable analysis of potential confounders revealed similar results across non-CLL 
leukaemia and subtypes. The most pronounced effect was observed across categories of 
birth year and year of first hire, where less risk was consistently observed in persons born 
earlier and/or hired earlier. Decreased risk was observed in women and non-Hispanic Whites 
compared with men and other races/ethnicities, respectively; however, among these factors, 
only CML in other races/ethnicities compared with non-Hispanic Whites was statistically 
significant (HR=4.1; 95% CI 1.3 to 12.7). More information on univariate analyses is 
available in the Web Appendix, table 5.
Multivariable analyses
Of variables tested for interaction with low-LET radiation, only race approached statistical 
significance (eg, non-CLL: Χ2=3.07, df=1, p=0.080). As observed previously,4 restricting 
analyses to Group I showed evidence of risk heterogeneity across facilities (Χ2=18.07, df=4, 
p=0.003). Positive dose-responses were observed in PNS workers (ERR per 100 mGy=3.7; 
95% CI 0.76 to 20.0) and SRS (ERR per 100 mGy=2.5; 95% CI 0.44 to 8.3), which 
influenced the overall estimate for the group (ERR per 100 mGy=0.12; 95% CI −0.16 to 
0.66). The estimate of non-CLL leukaemia risk for INL was also positive (ERR per 100 
mGy=0.03; 95% CI −0.23 to 0.81), although markedly less than Group I. There was no 
evidence of significant risk differences between Group I and Group II (Χ2=0.086, df=1, 
p=0.769).
Including sex in the model reduced risk estimates for non-CLL leukaemia by over 27%. 
Adjusting for race alone increased the estimate by nearly 40%. Including hire year by tertiles 
resulted in a 40% increase in the estimate compared with just under a 15% increase when 
controlling for hire year using RCS. Adjustment for benzene, SES or birth cohort resulted in 
less than 15% relative change. Similar results were obtained for CML, where final models 
were adjusted for race, sex and hire year. The model of AML risk was not influenced by sex 
or race, but was increased by 28% when including RCS terms for birth cohort, and 17% 
when including hire date. Given the strong association between birth cohort and AML 
compared with hire date and AML, subsequent models were controlled for birth date using 
spline terms. CLL risk estimates were influenced by sex (fourfold decrease), race (twofold 
increase), and birth cohort (10-fold increase using RCS).
Solving for radiation weights resulted in relatively large values for both high-LET 
components and a slight reduction in the risk per unit dose (table 1). Fixing weights in 
sensitivity analyses moderately increased ERR estimates of non-CLL leukaemia per unit 
dose. These patterns were consistent in lagged models; however, weight solutions were 
substantially reduced in windows-based models. For example, non-CLL risk from exposures 
6–14 years before the attained age of the case had solutions for plutonium and neutron 
weights of 0 (fixed bound) and 16, respectively, and the relative change in the ERR estimate 
was about 3%. Given evidence of only moderate high-LET effects and small percentages of 
exposed workers, we excluded plutonium and neutron doses from final models.
In general, positive, but non-statistically significant estimates of excess radiation-associated 
risk were observed in all lagged models except for CLL (table 2). There was no evidence of 
CLL radiogenicity in any model tested. The overall estimate of non-CLL risk was 0.09 (95% 
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CI −0.17 to 0.65) per 100 mGy (lagged 2 year), excluding CLL-indeterminate cases, and 
adjusting for sex, race and hire year. Including CLL-indeterminate cases in the model 
reduced the observed non-CLL risk (ERR per 100 mGy=0.03; 95% CI −1.5 to 0.38). Among 
leukaemia subtypes, the highest risk in lagged models was observed in CML (ERR per 100 
mGy=0.29; 95% CI <0 to 1.8; 6.3 year lag). Temporal risk patterns were clearly evident in 
time-windows-based models, and the most pronounced effect was observed for AML in the 
6–14-years window (ERR per 100 mGy=7.0; 95% CI 0.079 to 32.0), although CIs were 
wide. AML cases in the 6–14-years window had mean and maximum cumulative doses of 
3.8 and 71.2 mSv, respectively, while control mean and maximum doses were 2.1 and 137.4 
mSv, respectively. Results from alternate analyses of exposure lags and time since exposure 
using methods comparable with the previous study are reported in tables 6–8 of the Web 
Appendix.
Dose-response shape analyses
The results of fitting linear, linear-quadratic, categorical and RCS dose-response models of 
low-LET dose and non-CLL leukaemia are shown in figure 1. Figures for AML and CML 
dose-response modelling are available as figures 1 and 2 in the Web Appendix. Panel A 
shows the results of lagged models while Panel B shows results using the best-fit exposure 
window. Model convergence was not achieved for some time-windows-based models (ie, 
AML and CML linear-quadratic forms and CML RCS, see Web Appendix). The best fitting 
non-CLL and AML-lagged models were obtained from RCS (dashed lines) based on AIC 
and the LRT (table 3). The shape of the dose-response for AML was similar, whereby the 
lagged RCS and categorical plots show risk attenuation at cumulative doses below 10 mGy, 
followed by a sharp increase to 100 mGy before decreasing again. CML dose-response 
under a 5-year lag was best-fit to a linear model; however, inspection of RCS and 
categorical results suggested some attenuation at low and high doses, albeit diminished 
relative to AML. By contrast, there is little evidence of a departure from linearity in low-
dose regions of windows-based analyses of all outcomes, although non-linear models 
suggested some attenuation at higher doses. Alternate analyses examining the non-linearity 
of the dose-response at high doses are reported in the table 9 of the Web Appendix.
Two knot solutions (8.3 and 46.9 mGy) in the non-CLL PLS-lagged model indicated the 
points of departure from linearity in the low- and high-dose ranges. The slope estimates 
(ERR per 100 mGy) in each segment were: −6.6 (95% CI −9.8 to −0.92) for doses ≤8.3 
mGy; 2.0 (95% CI 0.30 to 4.2), for doses >8.3 and <46.9 mGy; and −0.16 (95% CI: <−0.22 
to 0.39) for doses ≥46.9 mGy. By contrast, the best fit of time-windows-based data was 
achieved in models using two segments with the knot at 20.1 mGy; however, the two 
segments were not statistically significantly different (p=0.86). The first segment was 
positive and statistically significant (ERR per 100 mGy=6.4; 95% CI 0.31 to 17.0). The 
second segment was negative and lacked statistical significance (ERR per 100 mGy= −0.82; 
95% CI −1.7 to 4.4).
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DISCUSSION
With 369 leukaemia cases in a population of 105 245 US nuclear workers, the current study 
is among the largest examining the leukaemogenicity of protracted ionising radiation 
exposures. The large size improved power compared with the previous analyses,34 and 
enabled analyses by leukaemia subtype. Estimates of risk per unit dose were consistent with 
results from previous studies (table 4), as were temporal patterns observed in populations 
exposed to known leukaemogens, such as benzene,2425 ionising radiation426–28 and 
smoking,29 whereby leukaemia risks lessen with time since exposure. Nevertheless, 
statistical power remains limited, leading to results which, in many cases, could be 
explained by the role of chance.
A non-linear dose-response was most evident in lagged models, whereby risk attenuation 
was observed at very low doses (<10 mGy) and at doses greater than 100 mGy. By contrast, 
strong departure from linearity was not evident in time-windows-based models, where risks 
appear greater than in lagged models. The elevated risk in windows-based models suggested 
temporal patterns in dose-response with time since exposure that were similar to, but more 
pronounced than, that observed in Japanese atomic bomb survivors26 and in other nuclear 
worker cohorts.428 AML risk appears particularly susceptible to temporal effects, where a 
30-fold change in risk was observed in the windows-based model compared with a lagged 
model. Without accounting for these temporal effects in studies of protracted exposures with 
long follow-up since periods of highest exposure, dose-response analyses may provide 
distorted results, as evident in the lagged models.
We examined the combined effects from low- and high-LET radiations and determined that 
there was little evidence of high-LET effects in this study. Solutions to weights in time-
windows-based models appeared in fair agreement with expectation.223233 By contrast, 
weights in lagged models were larger than expected, although CIs were wide. Exposure 
misclassification is a possible cause of spurious results given the sparseness and poor quality 
of available plutonium and neutron exposure measurements. It is also conceivable that other 
characteristics unique to the few plutonium workers or persons with measurable neutron 
dose may have led to inflated weight estimates. Last, the cohort was assembled from nuclear 
facilities selected to minimise high-LET dose contributions4; therefore, only a small number 
of study participants were significantly exposed to plutonium or neutrons.
Risk attenuation in the low-dose range was not evident in previous studies of workers 
employed at these facilities.48 The addition of low-exposed cases through extended follow-
up may be a source of the non-linear dose-response. Restricting the current study to non-
CLL cases with follow-up through 1990 (n=112 cases) reduced the non-linear low-dose 
effect and the best fit was obtained from a linear model (ERR per 100 mGy=0.6; 95% CI 
−0.06 to 2.0). Diminishing leukaemia risk with continued follow-up has been observed in 
populations exposed to benzene2434 and ionising radiation.3536 Rinsky et al34 reported a 
decline in the leukaemia standardised mortality ratio from 3.37 (95% CI 1.54 to 6.41) to 
2.56 (95% CI 1.43 to 4.22) after adding 15 years of follow-up to a cohort of white male 
benzene-exposed rubber hydrochloride workers. Silver et al24 also examined these workers 
using yearly follow-up information and found a fivefold decrease in the risk estimates from 
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1961 to 1996. In studies of ionising radiation, Boice et al35 reported decreased non-CLL 
leukaemia mortality after adding 9 years of follow-up to the study of Rocketdyne radiation 
workers,37 as did Krestinina et al36 after adding 6 years of follow-up to the Techa River 
cohort.38 Exposure profiles for these populations are temporally similar to the current study, 
where exposures occurred earlier in the follow-up period, and continued follow-up resulted 
in negligible additional dose. Given that leukaemia risk diminishes with time since 
exposure, it is less likely that new cases, who have not accrued additional dose in the 
extended follow-up period, are a consequence of ionising radiation exposure.
Risk attenuation at higher exposures is often observed in occupational studies, and may 
result from a number of causes, including a depletion of susceptible persons, biologic 
saturation, exposure misclassification or a healthy worker survivor bias.39 A healthy worker 
effect is less likely because leukaemia is not strongly related to lifestyle factors. Biologic 
saturation is also unlikely given that ‘high doses’ in this study are well below known 
thresholds for deterministic effects, and below doses that appear within the linear range in 
higher-dose studies. Exposure misclassification, although inevitable, is believed to be 
reduced by the availability of individual measurement data and the exclusion of early 
workers who were prone to highly uncertain dose estimates. Nevertheless, this source of 
uncertainty cannot be completely ruled out as cause for the observed attenuation. Some 
suggest that variations in risk in an exposed group may be attributable to small numbers of 
individuals who are predisposed to radiation-induced leukaemia.4041 In chronically exposed 
populations, those most susceptible to the disease present early after relevant exposure, and 
persons who are resistant remain leukaemia-free and continue to accumulate dose, which 
may explain the observed risk attenuation at higher doses and the dilution of risk with 
increased follow-up.
Of course, results from low-dose studies are highly susceptible to distortion by confounding 
and exposure measurement errors. Benzene, a known leukaemogen and a confounder in the 
previous study, was not associated with leukaemia risk in this study. A possible explanation 
is the exclusion of early workers who were at greatest risk of benzene exposure in the 
previous study. SES was used as a surrogate for lifestyle factors; therefore, a potential for 
incomplete control of smoking effects cannot be ruled out, although smoking is only weakly 
related to leukaemia. Regarding exposure, extensive searches for exposure records were 
conducted to estimate career doses; nevertheless, some exposure misclassification from 
incomplete or erroneous exposure data is likely. For example, we found that cases with 
exposures of 1.0 mGy, or less, were typically professionals who were hired later, were older 
at hire, and worked fewer years prior to termination compared with cases in the higher-dose 
categories. These patterns suggested a potential for previous dose during employment 
elsewhere and the lack of this information in dose-response analyses may have led to biased 
estimates. To examine this potential, non-CLL cases in the lowest-dose category (n=74) 
were matched to exposure data maintained on claimants under the Energy Employee 
Occupational Illness Compensation Programme Act. There were eight claimants identified, 
and four had additional exposure information in claimant files. Had these data been 
available for our study, a change in exposure category would have resulted in every case.
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Although we have offered several possible explanations, the cause for the non-linear dose-
response remains unknown. In the absence of known biases, one could interpret the 
attenuated risk at low doses as evidence of a threshold or protective effect. There has been 
considerable debate regarding the validity of the linear-no-threshold (LNT) dose-response 
model because the carcinogenicity of low- and very low-dose radiation exposure is largely 
uncertain.42–48 Although threshold or protective effects at low doses cannot be ruled out by 
our findings, we did not observe attenuated risk in time-windows-based models that very 
likely represent the most relevant period of risk following exposure.
CONCLUSIONS
Positive, but imprecise estimates of excess relative risk were observed for all leukaemia 
outcomes except the CLL subtype. Non-CLL leukaemia risk was time-dependent, where 
peak excess risk per unit dose was observed at select times prior to disease onset. Marked 
improvements in estimates were observed in time-windows analyses, where linear dose-
response models prevailed over other forms tested. Overall, the point estimates and temporal 
patterns observed in this study were in reasonable agreement with previous results; however, 
some dilution from extended follow-up without concomitant increases in dose was apparent.
Risk models using exposure lags exhibited attenuated risk in the low-dose (<10 mGy) and 
high-dose (>100 mGy) regions. The low-dose attenuation disappeared in models based on 
dose accrued in time-windows associated with maximum leukaemia risk prior to attained 
age of the case. Risk attenuation in the low-dose region is particularly difficult to explain 
given that similar results were not observed in previous studies; however, there is some 
evidence that extended follow-up and exposure misclassification in the low-dose range may 
be partially at fault. Low-dose effects, which are most important for risk assessment, are 
much more difficult to discern compared with the effects at high doses given limited 
statistical power and results that are highly susceptible to bias. Future research should focus 
on methods that improve evaluations of the dose-response, particularly in the low-dose 
range. In particular, better collection of career dose information may greatly reduce the 
potential for exposure misclassification. For example, future studies could be markedly 
improved by a consolidation of exposure information from NRC, DOE and military sources 
into a national dose registry.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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What this study adds
• Questions remain concerning the translation of risks observed in Japanese 
atomic bomb survivors to working populations who are exposed to low doses of 
ionising radiation delivered at low rates of exposure.
• With 369 leukaemia deaths identified in a pooled cohort of over 100 000 nuclear 
workers from six major US facilities, this study is among the largest leukaemia 
studies ever conducted with low-dose radiation. The large study size enabled 
analysis by leukaemia subtype and detailed examination of dose-response 
characteristics that have not been completed prior.
• Positive but imprecise estimates of leukemia risk, which increased with dose, 
were observed for myeloid leukaemias but not for chronic lymphocytic 
leukaemia (CLL). These findings were consistent with previous studies that 
suggest a weak leukaemogenicity of ionising radiation for non-CLL subtypes.
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Figure 1. 
Mortality from leukaemia, excluding the chronic lymphocytic subtype, and cumulative 
absorbed dose to bone marrow. (A) Two-year lag; (B) 6–14-year window. Solid line: linear; 
long dashed line: linear-quadratic; short dashed line: restricted cubic spline (RCS); filled 
squares: category midpoints (with 95% CI shown by error bars).
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Table 4
Leukaemia ERR at 100 mGy exposure by subtype and by study
Study Non-CLL AML CML CLL
Current study 0.09 (95% CI −0.17 to 0.65) 0.22 (95% CI −0.19 to 
1.2)
0.29 (95% CI <0 to 2.6) −0.03 (95% CI −0.16 to 
0.74)
264 decedents 150 decedents 52 decedents 74 decedents
LCCS34 0.26 (95% CI <−0.10 to 1.03) NR NR −0.20 (95% CI <0 to 1.4)
184 decedents 43 decedents
15-country study*730 0.196 (90% CI −0.026 to 
0.59)
−0.41 (90% CI −0.76 to 
0.17)
1.0 (90% CI −0.086 to 
4.02)
−0.17 (95% CI −0.89 to 
0.40)
196 decedents 81 decedents 45 decedents 47 decedents
Three-country study31 0.22 (90% CI 0.013 to 0.57) 0.34 (90% CI <0 to 1.49) 1.1 (90% CI 0.29 to 
3.09)
−0.09 (90% CI <0 to 
0.73)
119 decedents 32 decedents 28 decedents 27 decedents
NRRW6 0.17 (90% CI 0.006 to 0.43) 0.12 (90% CI −0.12 to 
0.65)
0.33 (90% CI 0.04 to 
0.93)
<−0.19 (90% CI <−0.19 
to 0.12)
198 decedents 102 decedents 44 decedents 69 decedents
LSS†26 0.47 (90% CI 0.35 to 0.64) 0.43 (90% CI 0.27 to 
0.66)
0.64 (90% CI 0.30 to 
1.37)
NR
310 decedents‡ 124 decedents 58 decedents
*AML and CLL results were calculated using a log-linear relative risk model of the form RR(d)=exp(βd) and ERR=RR−1.
†
Based on a linear ERR model without effect modification of the form ERR(d)=βd.
‡Also included seven CLL cases and 121 leukaemias not specified as AML or CML.
AML, acute myeloid leukaemia; CML, chronic myeloid leukaemia; CLL, chronic lymphocytic leukaemia; ERR, excess relative risk; LCCS, 
NIOSH Leukaemia Mortality Case control Study; LSS, Life-Span Study of Japanese Atomic Bomb Survivors; NC, not calculable; NR, not 
reported; NRRW, UK National Registry of Radiation Workers.
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